Suppr超能文献

上海浦东骨肉瘤死亡率的模式与趋势:一项基于人群的研究

Patterns and Trends of the Mortality From Bone Cancer in Pudong, Shanghai: A Population-Based Study.

作者信息

Ma Gui-Fen, Bao Qi-Yuan, Zhang Hong-Yue, Chen Yi-Chen, Zhang Yue, Jiang Zhao-Yong, Li Xiao-Pan, Zhang Ju-Hua

机构信息

Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.

Center for Cancer Prevention and Treatment, Zhongshan Hospital, Fudan University, Shanghai, China.

出版信息

Front Oncol. 2022 May 16;12:873918. doi: 10.3389/fonc.2022.873918. eCollection 2022.

Abstract

INTRODUCTION

The burden of cancer-related mortality of common malignancies has been reported worldwide. However, whether bone cancer (BC), as a highly aggressive and heterogeneous group of rare cancers, followed a similar or distinct epidemiological pattern during such process remains largely unknown. We aimed to analyze the mortality and the temporal trends of BC in relation to gender, age, and premature death in Shanghai, China.

METHODS

We conducted a population-based analysis of the mortality data of BC in Shanghai Pudong New Area (PNA) from 2005 to 2020. The epidemiological characteristics and long-term trends in crude mortality rates (CMRs), age-standardized mortality rates worldwide (ASMRWs), and rate of years of life lost (YLL) was analyzed using the Joinpoint regression program. The demographic and non-demographic factors affecting the mortality rate were evaluated by the decomposition method.

RESULTS

There are 519 BC-specific deaths accounting for 0.15% of all 336,823 deaths and 0.49% of cancer-specific death in PNA. The CMR and ASMRW of BC were 1.15/10 person-year and 0.61/10 person-year, respectively. The YLL due to premature death from BC was 6,539.39 years, with the age group of 60-69 years having the highest YLL of 1,440.79 years. The long-term trend of CMR, ASMRW, and YLL rate significantly decreased by -5.14%, -7.64%, and -7.27%, respectively, per year (all < 0.05) in the past 16 years. However, the proportion of BC-specific death within the total cancer-specific death dropped to a plateau without further improvement since 2016, and a remarkable gender and age disparity was noticed in the observed reduction in mortality. Specifically, the elderly benefited less but accounted for a larger percentage of BC population in the last decades. Although the overall mortality of BC decreased, there was still a significant upward trend toward an increased mortality rate caused by the aging of the BC patients.

CONCLUSION

Our study provides novel insights on the epidemiological characteristics and longitudinal dynamics of BC in a fast urbanization and transitioning city. As a rare disease affecting all ages, the burden of BC among the elderly emerged to form an understudied and unmet medical need in an aging society.

摘要

引言

全球范围内已报道了常见恶性肿瘤的癌症相关死亡率负担。然而,骨癌(BC)作为一组具有高度侵袭性且异质性的罕见癌症,在此过程中是否遵循相似或不同的流行病学模式,在很大程度上仍不清楚。我们旨在分析中国上海骨癌在性别、年龄和过早死亡方面的死亡率及时间趋势。

方法

我们对2005年至2020年上海浦东新区(PNA)骨癌的死亡率数据进行了基于人群的分析。使用Joinpoint回归程序分析粗死亡率(CMR)、全球年龄标准化死亡率(ASMRW)和寿命损失年率(YLL)的流行病学特征及长期趋势。通过分解方法评估影响死亡率的人口统计学和非人口统计学因素。

结果

在PNA,有519例骨癌特异性死亡,占所有336,823例死亡的0.15%,占癌症特异性死亡的0.49%。骨癌的CMR和ASMRW分别为1.15/10人年和0.61/10人年。因骨癌过早死亡导致的YLL为6539.39年,60 - 69岁年龄组的YLL最高,为1440.79年。在过去16年中,CMR、ASMRW和YLL率的长期趋势分别显著下降,每年下降-5.14%、-7.64%和-7.27%(均P < 0.05)。然而,自2016年以来,骨癌特异性死亡在总癌症特异性死亡中的比例降至平稳状态,没有进一步改善,并且在观察到的死亡率下降中存在明显的性别和年龄差异。具体而言,在过去几十年中,老年人受益较少,但在骨癌人群中占比更大。尽管骨癌的总体死亡率下降,但由于骨癌患者老龄化导致的死亡率仍有显著上升趋势。

结论

我们的研究为快速城市化和转型城市中骨癌的流行病学特征及纵向动态提供了新的见解。作为一种影响所有年龄段的罕见疾病,在老龄化社会中,老年人的骨癌负担成为一个研究不足且未得到满足的医疗需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaef/9165546/4a67ecd21555/fonc-12-873918-g001.jpg

相似文献

1
Patterns and Trends of the Mortality From Bone Cancer in Pudong, Shanghai: A Population-Based Study.
Front Oncol. 2022 May 16;12:873918. doi: 10.3389/fonc.2022.873918. eCollection 2022.
7
The burden and trend of liver metastases in Shanghai, China: a population-based study.
Eur J Cancer Prev. 2023 Nov 1;32(6):517-524. doi: 10.1097/CEJ.0000000000000823. Epub 2023 Jul 3.
10
CHD-related/specific mortality of 3.17 million people in a transitioning region: trends, risk factors, and prevention.
Aging Clin Exp Res. 2023 Dec;35(12):3147-3156. doi: 10.1007/s40520-023-02618-1. Epub 2023 Nov 20.

引用本文的文献

本文引用的文献

3
The 2020 WHO Classification of Tumors of Bone: An Updated Review.
Adv Anat Pathol. 2021 May 1;28(3):119-138. doi: 10.1097/PAP.0000000000000293.
7
Bone sarcomas in the immunotherapy era.
Br J Pharmacol. 2021 May;178(9):1955-1972. doi: 10.1111/bph.14999. Epub 2020 Feb 18.
8
Urban-Rural Disparity in Cancer Incidence, Mortality, and Survivals in Shanghai, China, During 2002 and 2015.
Front Oncol. 2018 Dec 3;8:579. doi: 10.3389/fonc.2018.00579. eCollection 2018.
10
Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
BMC Musculoskelet Disord. 2018 Aug 18;19(1):297. doi: 10.1186/s12891-018-2217-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验